Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 500

1.

Lynch Syndrome Screening in Gynecological Cancers: Results of an International Survey with Recommendations for Uniform Reporting Terminology for Mismatch Repair Immunohistochemistry Results.

Ryan N, Wall J, Crosbie EJ, Arends M, Bosse T, Arif S, Faruqi A, Frayling I, Ganesan R, Hock YL, McMahon R, Manchanda R, McCluggage WG, Mukonoweshuro P, van Schalkwyk G, Side L, Smith JH, Tanchel B, Gareth Evans D, Gilks CB, Singh N; FRCPath.

Histopathology. 2019 Jul 16. doi: 10.1111/his.13925. [Epub ahead of print]

PMID:
31310679
2.

Reclassifying endometrial carcinomas with a combined morphological and molecular approach.

Carlson J, McCluggage WG.

Curr Opin Oncol. 2019 Jun 28. doi: 10.1097/CCO.0000000000000560. [Epub ahead of print]

PMID:
31261170
3.

Adult Granulosa Cell Tumor With High-grade Transformation: Report of a Series With FOXL2 Mutation Analysis.

Fashedemi Y, Coutts M, Wise O, Bonhomme B, Baker G, Kelly PJ, Soubeyran I, Catherwood MA, Croce S, McCluggage WG.

Am J Surg Pathol. 2019 May 31. doi: 10.1097/PAS.0000000000001296. [Epub ahead of print]

PMID:
31162286
4.

Low-grade Serous Carcinoma Arising in Inguinal Nodal Endosalpingiosis: Report of 2 Cases and Literature Review.

Sah S, Fulmali R, McCluggage WG.

Int J Gynecol Pathol. 2019 May 30. doi: 10.1097/PGP.0000000000000613. [Epub ahead of print]

PMID:
31157685
5.

Reproducibility of lymphovascular space invasion (LVSI) assessment in endometrial cancer.

Peters EEM, Bartosch C, McCluggage WG, Genestie C, Lax SF, Nout R, Oosting J, Singh N, Smit HCSH, Smit VTHBM, Van de Vijver KK, Bosse T.

Histopathology. 2019 Jul;75(1):128-136. doi: 10.1111/his.13871. Epub 2019 Jun 10.

PMID:
31155736
6.

High EMSY expression defines a BRCA-like subgroup of high-grade serous ovarian carcinoma with prolonged survival and hypersensitivity to platinum.

Hollis RL, Churchman M, Michie CO, Rye T, Knight L, McCavigan A, Perren T, Williams ARW, McCluggage WG, Kaplan RS, Jayson GC, Oza A, Harkin DP, Herrington CS, Kennedy R, Gourley C.

Cancer. 2019 Jun 2. doi: 10.1002/cncr.32079. [Epub ahead of print]

PMID:
31154673
7.

Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data.

Cohen PA, Powell A, Böhm S, Gilks CB, Stewart CJR, Meniawy TM, Bulsara M, Avril S, Brockbank EC, Bosse T, de Azevedo Focchi GR, Ganesan R, Glasspool RM, Howitt BE, Kim HS, Lee JY, Le ND, Lockley M, Manchanda R, Mandalia T, McCluggage WG, McNeish I, Midha D, Srinivasan R, Tan YY, van der Griend R, Yunokawa M, Zannoni GF; HGSC CRS Collaborative Network (Supplementary 1), Singh N.

Gynecol Oncol. 2019 May 19. pii: S0090-8258(19)31181-3. doi: 10.1016/j.ygyno.2019.04.679. [Epub ahead of print] Review.

8.

ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease.

Colombo N, Sessa C, Bois AD, Ledermann J, McCluggage WG, McNeish I, Morice P, Pignata S, Ray-Coquard I, Vergote I, Baert T, Belaroussi I, Dashora A, Olbrecht S, Planchamp F, Querleu D; ESMO–ESGO Ovarian Cancer Consensus Conference Working Group.

Int J Gynecol Cancer. 2019 May 2. pii: ijgc-2019-000308. doi: 10.1136/ijgc-2019-000308. [Epub ahead of print]

PMID:
31048403
9.

ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†.

Colombo N, Sessa C, du Bois A, Ledermann J, McCluggage WG, McNeish I, Morice P, Pignata S, Ray-Coquard I, Vergote I, Baert T, Belaroussi I, Dashora A, Olbrecht S, Planchamp F, Querleu D; ESMO–ESGO Ovarian Cancer Consensus Conference Working Group .

Ann Oncol. 2019 May 1;30(5):672-705. doi: 10.1093/annonc/mdz062.

PMID:
31046081
10.

A Clinicopathologic Study and Descriptive Analysis of "Atypical Endosalpingiosis".

Talia KL, Fiorentino L, Scurry J, McCluggage WG.

Int J Gynecol Pathol. 2019 Apr 24. doi: 10.1097/PGP.0000000000000600. [Epub ahead of print]

PMID:
31033796
11.

An international, phase III randomized trial in patients with mucinous epithelial ovarian cancer (mEOC/GOG 0241) with long-term follow-up: and experience of conducting a clinical trial in a rare gynecological tumor.

Gore M, Hackshaw A, Brady WE, Penson RT, Zaino R, McCluggage WG, Ganesan R, Wilkinson N, Perren T, Montes A, Summers J, Lord R, Dark G, Rustin G, Mackean M, Reed N, Kehoe S, Frumovitz M, Christensen H, Feeney A, Ledermann J, Gershenson DM.

Gynecol Oncol. 2019 Jun;153(3):541-548. doi: 10.1016/j.ygyno.2019.03.256. Epub 2019 Apr 18.

12.

Letter to the editor, Reply to: Cecile Colpaert et al.: Ultrastaging of sentinel lymph nodes in gynecological cancer: Repeating the story of breast cancer?

Cibula D, McCluggage WG.

Gynecol Oncol Rep. 2019 Mar 26;28:94-95. doi: 10.1016/j.gore.2019.03.013. eCollection 2019 May. No abstract available.

13.

The dilemma of early preventive oophorectomy in familial small cell carcinoma of the ovary of hypercalcemic type.

Pejovic T, McCluggage WG, Krieg AJ, Xu F, Lee DM, Witkowski L, Foulkes WD.

Gynecol Oncol Rep. 2019 Feb 17;28:47-49. doi: 10.1016/j.gore.2019.02.002. eCollection 2019 May.

14.

Uterine and vaginal sarcomas resembling fibrosarcoma: a clinicopathological and molecular analysis of 13 cases showing common NTRK-rearrangements and the description of a COL1A1-PDGFB fusion novel to uterine neoplasms.

Croce S, Hostein I, Longacre TA, Mills AM, Pérot G, Devouassoux-Shisheboran M, Velasco V, Floquet A, Guyon F, Chakiba C, Querleu D, Khalifa E, Mayeur L, Rebier F, Leguellec S, Soubeyran I, McCluggage WG.

Mod Pathol. 2019 Jul;32(7):1008-1022. doi: 10.1038/s41379-018-0184-6. Epub 2019 Mar 16.

PMID:
30877273
15.

Micropapillary Cervical Adenocarcinoma: A Clinicopathologic Study of 44 Cases.

Alvarado-Cabrero I, McCluggage WG, Estevez-Castro R, Pérez-Montiel D, Stolnicu S, Ganesan R, Vella J, Castro R, Canedo-Matute J, Gomez-Cifuentes J, Rivas-Lemus VM, Park KJ, Soslow RA, Oliva E, Valencia-Cedillo R.

Am J Surg Pathol. 2019 Jun;43(6):802-809. doi: 10.1097/PAS.0000000000001245.

PMID:
30864975
16.

BRCA1 and MAD2 Are Coexpressed and Are Prognostic Indicators in Tubo-ovarian High-Grade Serous Carcinoma.

Byrne T, Nelson L, Beirne JP, Sharpe D, Quinn JE, McCluggage WG, Robson T, Furlong F.

Int J Gynecol Cancer. 2018 Mar;28(3):472-478. doi: 10.1097/IGC.0000000000001214.

PMID:
30814209
17.

Uterine Endometrial Stromal Tumors With Limited Infiltration: First Report of a Case Series Indicating Potential for Malignant Behavior.

Moore M, McCluggage WG.

Int J Gynecol Pathol. 2019 Feb 21. doi: 10.1097/PGP.0000000000000593. [Epub ahead of print]

PMID:
30807369
18.

Ovarian Combined Low-grade Serous and Mesonephric-like Adenocarcinoma: Further Evidence for A Mullerian Origin of Mesonephric-like Adenocarcinoma.

McCluggage WG, Vosmikova H, Laco J.

Int J Gynecol Pathol. 2018 Dec 19. doi: 10.1097/PGP.0000000000000573. [Epub ahead of print]

PMID:
30575604
19.

Somatic genetic alterations in synchronous and metachronous low-grade serous tumours and high-grade carcinomas of the adnexa.

Murali R, Selenica P, Brown DN, Cheetham RK, Chandramohan R, Claros NL, Bouvier N, Cheng DT, Soslow RA, Weigelt B, McCluggage WG.

Histopathology. 2019 Mar;74(4):638-650. doi: 10.1111/his.13796. Epub 2019 Jan 15.

PMID:
30565721
20.

Pathologic Prognostic Factors in Endometrial Carcinoma (Other Than Tumor Type and Grade).

Singh N, Hirschowitz L, Zaino R, Alvarado-Cabrero I, Duggan MA, Ali-Fehmi R, Euscher E, Hecht JL, Horn LC, Ioffe O, Matias-Guiu X, McCluggage WG, Mikami Y, Ordi J, Parkash V, Quddus MR, Quick CM, Staebler A, Zaloudek C, Nucci M, Malpica A, Oliva E.

Int J Gynecol Pathol. 2019 Jan;38 Suppl 1:S93-S113. doi: 10.1097/PGP.0000000000000524.

Supplemental Content

Loading ...
Support Center